Table 1. Association between miR-93 expression and clinicopathological characteristics of patients with OS.
Characteristics | Cases | miR-93 | P-value | |
---|---|---|---|---|
High | Low | |||
Age (years) | 0.778 | |||
≥18 | 24 | 16 | 8 | |
<18 | 38 | 24 | 14 | |
Gender | 0.731 | |||
Female | 32 | 20 | 12 | |
Male | 30 | 20 | 10 | |
Tumor size, cm | 0.021* | |||
≤5 | 32 | 25 | 7 | |
>5 | 30 | 15 | 15 | |
TNM stage | 0.012* | |||
I | 33 | 26 | 7 | |
II/III | 29 | 14 | 15 | |
Distant metastasis | 0.034* | |||
No | 31 | 24 | 7 | |
Yes | 31 | 16 | 15 | |
Location | 0.080 | |||
Femur/Tibia | 29 | 22 | 7 | |
Elsewhere | 33 | 18 | 15 |
Statistical analyses were performed by the χ2 test.
P<0.05 was considered significant.